As of 31 Dec 2025, 0 institutional investors reported holding shares of MYRIAD GENETICS INC - CALL.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | $6.15 | 0 | |||
| 2025 Q3 | $7.19 | 0 | |||
| 2025 Q2 | $4.93 | 0 | |||
| 2025 Q1 | $8.81 | 0 | |||
| 2024 Q4 | $13.10 | 0 | |||
| 2024 Q3 | $27.32 | 0 | |||
| 2024 Q2 | $24.46 | 0 | |||
| 2024 Q1 | $21.28 | 0 | |||
| 2023 Q4 | $19.14 | 0 | |||
| 2023 Q3 | $16.04 | 0 | |||
| 2023 Q2 | $23.11 | 0 | |||
| 2023 Q1 | $23.23 | 0 | |||
| 2022 Q4 | $14.51 | 0 | |||
| 2022 Q3 | $19.00 | 0 | |||
| 2022 Q2 | $18.16 | 0 | |||
| 2022 Q1 | $25.20 | 0 | |||
| 2021 Q4 | $27.57 | 0 | |||
| 2021 Q3 | $31.71 | 0 | |||
| 2021 Q2 | $30.47 | 0 | |||
| 2021 Q1 | $1533.41 | 0 | |||
| 2020 Q4 | $994.42 | 0 | |||
| 2020 Q3 | $657.58 | 0 | |||
| 2020 Q2 | $571.71 | 0 | |||
| 2020 Q1 | $719.68 | 0 | |||
| 2019 Q4 | $1359.76 | 0 | |||
| 2019 Q3 | $28.75 | 0 | |||
| 2019 Q2 | $1402.26 | 0 | |||
| 2019 Q1 | $3315.44 | 0 | |||
| 2018 Q4 | $1464.15 | 0 | |||
| 2018 Q3 | $2322.98 | 0 | |||
| 2018 Q2 | $1881.50 | 0 | |||
| 2018 Q1 | $42.73 | 0 | |||
| 2017 Q4 | $201.01 | 0 | |||
| 2017 Q3 | $593.10 | 0 | |||
| 2017 Q2 | $167.03 | 0 | |||
| 2017 Q1 | $80.99 | 0 | |||
| 2016 Q4 | $16.63 | 0 | |||
| 2016 Q3 | $20.55 | 0 | |||
| 2016 Q2 | $30.61 | 0 | |||
| 2016 Q1 | $37.43 | 0 | |||
| 2015 Q4 | $43.16 | 0 | |||
| 2015 Q3 | $37.48 | 0 | |||
| 2015 Q2 | $33.99 | 0 | |||
| 2015 Q1 | $35.39 | 0 | |||
| 2014 Q4 | $34.07 | 0 | |||
| 2014 Q3 | $38.57 | 0 | |||
| 2014 Q2 | $38.92 | 0 | |||
| 2014 Q1 | $34.19 | 0 |